NJ Center for Clinical and Translational Sciences

新泽西临床和转化科学中心

• 批准号: 7216033
• 负责人: KATHLEEN W. SCOTTO
• 金额: $ 23.33万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-21 至 2008-09-20
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7216033
• 关键词: Internet; NIH Roadmap Initiative tag; clinical research; curriculum; educational resource design /development; health science research; health science research support; information dissemination; information systems; interdisciplinary collaboration; science education

DESCRIPTION (provided by applicant): New Jersey is uniquely suited as the host to a unique consortium of shareholders committed to the rapid and effective translation of basic biomedical discoveries into new tools for prevention, diagnosis and treatment of disease. It has a dense and diverse urban population, one of the largest biotechnology and pharmaceutical industries in the world, a government committed to new innovations and technology and a community with a strong legacy of advocacy for biomedical advances. The New Jersey Center for Clinical and Translational Sciences (NJCCTS) will tap into these unique resources, bringing together scientists, clinicians, industry, community and the State to forge new and novel alliances that will transform the process of clinical/ translational research in our State and country. We will work as teams, determining needs, directing research to fulfill those needs and cooperating to anticipate and remove the traditional impediments to success. We believe that this paradigm shift from a supply-driven to a user-driven prioritization of research goals will transform the way we accomplish the translation of basic scientific discoveries into cures. Importantly, as part of the process, we will train the teams of the future, so that what seems novel and innovative to us today will be common practice for the next generation. As part of the planning process, we propose to: 1) Develop the administrative structure that will support and nurture the growth of the NJCCTS, assemble and empower its shareholders, define its research directions, and define the critical attributes required for the Director of this unique and novel consortium; 2) Design a core curriculum that will provide the training necessary to develop a novel team approach to clinical/translational research. 3) Develop the hub of the NJCCTS, a research core facility that will nurture young and/or new clinical/translational investigators, provide an entry point for industry collaborators, and act as a central "matchmaker" - facilitating collaborations, identifying resources and moving projects through the pipeline. 4) Establish a Faculty Development Committee to devise a plan to ensure that team scientists are appropriately incentivized and rewarded and 5) Craft a web-based information system that will allow for seamless interactions among our partner institutions and with the national CTS consortium.

描述（由申请人提供）：新泽西非常适合作为一个独特的股东财团，致力于将基本生物医学发现快速转化为预防，诊断和治疗疾病的新工具。它具有密集和多样化的城市人口，是世界上最大的生物技术和制药行业之一，政府致力于新的创新和技术，以及一个具有强大倡导生物医学进步的社区。新泽西州临床和转化科学中心（NJCCTS）将利用这些独特的资源，将科学家，临床医生，工业，社区，社区和州聚集在一起，以建立新的和新颖的联盟，这些联盟将改变我们州和国家的临床/转化研究过程。我们将担任团队，确定需求，指导研究以满足这些需求并进行合作，以期待和消除成功的成功障碍。我们认为，从供应驱动到用户驱动的研究目标的优先级的范式转变将改变我们将基本科学发现转化为治疗方法的方式。重要的是，作为流程的一部分，我们将培训未来的团队，以便今天对我们来说似乎是新颖和创新的，这对于下一代来说是普遍的实践。 作为计划过程的一部分，我们建议：1）建立将支持和培育NJCCT的增长，组装和授权其股东，定义其研究方向的行政结构，并确定这个独特和新颖财团所需的关键属性； 2）设计一种核心课程，该课程将提供必要的培训，以开发一种新型的临床/翻译研究团队方法。 3）开发NJCCTS的枢纽，NJCCT是一种研究核心设施，它将培养年轻和/或新的临床/转化调查人员，为行业合作者提供入口点，并充当中心的“媒人” - 促进合作，识别资源并通过管道迁移项目。 4）建立一个教师发展委员会，以制定一项计划，以确保团队科学家得到适当激励和奖励和奖励，5）制定基于网络的信息系统，该系统将允许我们的合作伙伴机构和国家CTS财团之间进行无缝互动。